IRESCO Competitors

NIH is the only agency of its kind. We impact the health of the country and the world through unique and innovative medical research. Did you know that NIH is the largest public funder of biomedical research in the world, investing more than $32 billion a year to enhance life, and reduce illness and disability? NIH funded research has led to breakthroughs and new treatments, helping people live longer, healthier lives, and building the research foundation that drives discovery. Whether you are graduating with a bachelor's degree, working on your doctoral degree, entering the workforce for the first time, or changing careers, NIH offers a place for you to start and plenty of room to grow your career. When you join us, you’re not just advancing your career — you’re driving the health of our country forward. Official LinkedIn Account of the NIH. Privacy policy: http://go.usa.gov/x9svN Comment policy: https://bit.ly/3G6xq94 Engagement ≠ endorsement

The International Association for the Study of Pain (IASP) works to support research, education, clinical treatment, and better patient outcomes for all pain conditions. For nearly 50 years, IASP has been a leading global authority on pain and continues to be the largest multidisciplinary association in the field of pain. With more than 7,000 members representing over 130 countries, 95 national chapters, and 24 Special Interest Groups (SIGs), IASP fosters the exchange of ideas and education to stimulate and support the study of pain and to translate that knowledge into improved pain relief worldwide.

Founded in 1983 as the American Academy of Algology, the American Academy of Pain Medicine (AAPM) has evolved as the primary organization for clinicians practicing the specialty of pain medicine. https://painmed.org/shared-interest-groups/ AAPM has more than 2,000 members and is committed to its mission of optimizing the health of patients in pain and eliminating the major public health problem of pain by advancing the practice and specialty of pain medicine.